170.10
-11.14 (-6.15%)
-11.14 (-6.15%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CRISPR Therapeutics AG | CRSP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -11.14 | -6.15% | 170.10 | 17:06:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 179.09 | 168.51 | 183.00 | 169.53 | 181.24 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 169.61 | 170.00 | 0.39 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 65,750 | 2,453,625 | $ 174.76 | $ 428,801,394 | 2,450,130 | 32.00 - 220.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:07:12 | 32 | $ 169.53 | USD |
CRISPR Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 12.78B | 75.13M | 66.65M | $ 289.59M | $ - | 0.98 | -58.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
CRISPR Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRSP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 207.48 | 208.18 | 168.51 | 188.71 | 2,184,782 | -37.38 | -18.02% |
| 1 Month | 169.93 | 220.21 | 148.25 | 183.89 | 2,649,071 | 0.17 | 0.1% |
| 3 Months | 86.55 | 220.21 | 85.00 | 162.77 | 1,860,210 | 83.55 | 96.53% |
| 6 Months | 91.29 | 220.21 | 76.71 | 135.37 | 1,356,635 | 78.81 | 86.33% |
| 1 Year | 52.50 | 220.21 | 32.00 | 103.66 | 1,188,255 | 117.60 | 224.0% |
| 3 Years | 41.04 | 220.21 | 21.65 | 70.73 | 1,018,726 | 129.06 | 314.47% |
| 5 Years | 15.00 | 220.21 | 11.63 | 66.95 | 778,293 | 155.10 | 1,034.0% |
CRISPR Therapeutics Description
| CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need. |
